| Document |
Document Title |
|
JP4754071B2 |
A composition comprising a polymer containing a compound represented by Formula (1) or a salt thereof as a constituent monomer, or a polymer containing a structure represented by Formula (9) as a partial structure is used for protecting ...
|
|
JP4749579B2 |
|
|
JP2011522776A |
The present patent application relates to cosmetic compositions comprising cationic compounds of quaternary ammonium esters derived from 2-[2-(diethylamino)ethoxy]ethanol type, to the use of these cationic compounds, in particular as con...
|
|
JP2011140455A |
To provide a method for producing an efficient and economical highly pure ionic vinyl monomer.The method for synthesizing the ionic vinyl monomer represented by formula (1) (wherein, R1 is H or methyl; R2 and R3 are each independently id...
|
|
JP4727994B2 |
A fungicidally active compound of formula (1): where Het is a substituted 5- or 6-membered heterocyclic ring; R1 is hydrogen, formyl, CO-C1-4 alkyl, COO-C1-4 alkyl, C1-4 alkoxy(C1-4)alkylene, CO-C1-4 alkylenoxy(C1-4)alkyl, propargyl or a...
|
|
JP4699804B2 |
|
|
JP4699803B2 |
|
|
JP4698773B2 |
The properties of biologically active compounds, for example drugs and agrochemicals, which contain in their molecular structure one or more functional groups selected from alcohol, ether, phenyl, amino, amido, thiol, carboxylic acid and...
|
|
JP2011102295A |
To provide a method for efficiently synthesizing (R)-2-(3-diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)-
phenol isobutyrate (Fesoterodine) and its (S)-enantiomer fesoterodine, by which the synthesis of the Fesoterodine and its (S)-e...
|
|
JPWO2009090791A1 |
An object of the present invention is to produce a dialkylaminoalkyl (meth) acrylate quaternary salt by reacting a dialkylaminoalkyl (meth) acrylate with a gaseous quaternizing agent in an aqueous solution of a dialkylaminoalkyl (meth) a...
|
|
JP4679136B2 |
|
|
JP4676061B2 |
Compounds having Formula (I) are useful for modulating the glucocorticoid receptor in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of treating immune, autoimmune, inflammatory, ...
|
|
JP4674046B2 |
The invention provides novel compounds of the Formula (I) that stimulate rates of glucose oxidation in myocardial cells wherein W, Cyc, p, , X, Z, R, K-, R, R<1>, R<2>, R<3>,R<4>,< >I and n are as defined for Formula (I) herein. The inve...
|
|
JP4672164B2 |
|
|
JP4658895B2 |
The invention concerns novel derivatives of 3,3-diphenylpropylamines, methods for their preparation, pharmaceutical compositions containing the novel compounds, and the use of the compounds for preparing drugs. More particularly, the inv...
|
|
JP4645925B2 |
|
|
JP4646921B2 |
Ibopamine malcate salt (1:1), method for preparing it and pharmaceutical composition containing it.
|
|
JP4645810B2 |
A polymer electrolyte-forming composition containing (A) a quaternary ammonium salt of general formula (1) below and (B) an ionic liquid can be converted into a polymer without compromising the excellent properties of the ionic liquid, t...
|
|
JP4641827B2 |
|
|
JP4641112B2 |
|
|
JP2011037820A |
To provide a method for efficiently recovering a reusable active catalyst from reaction liquid and reusing as at least a part of the catalyst used for next time in producing an objective (meth)acylate by performing the ester-interchange ...
|
|
JPWO2009047905A1 |
The present invention provides a selective ester production process for alcoholic hydroxyl groups, which proceeds under chemically mild conditions and has environmental friendliness, operability, and economy. The present invention relate...
|
|
JP4634286B2 |
A process for the purification of (S)-4-äÄ3-(dimethylamino)ethylÜ-1H-indol-5ylÜ-methylü-2
-oxazolidinone and non-solvated, pure (S)-4-äÄ3-(dimethylamino) ethylÜ-1H-indol-5y1Ü-methylü-2-oxazolidinone.
|
|
JP2011502471A |
The invention relates to a process for preparing an enantiomerically and/or diastereomerically enriched ester or thioester having at least two adjacent chiral centres, wherein a mixture of stereoisomers of a secondary alcohol or thiol ha...
|
|
JP4602671B2 |
The present invention relates to open chain alkoxyamine compounds, a polymerizable composition comprising a) at least one ethylenically unsaturated monomer and b) at least one open chain alkoxyamine compound. Further aspects of the prese...
|
|
JP2010280665A |
To provide a new NSAID (nitrosated nonsteroidal antiinflammatory drug), a composition and a method for using the same.There are provided an NSAID of the formula, its pharmaceutically acceptable salt, and a new composition containing at l...
|
|
JP4595040B2 |
The invention relates to compounds of formula (I), wherein R1, R2, R1a, R2a, R3, R4, A, B, X, W and n are as defined in the description, and pharmaceutically acceptable salts of such compounds. These compounds are useful as calcium chann...
|
|
JP4593199B2 |
To obtain an acrylic acid ester compound that has excellent radical polymerizability and charge transport properties in an organic semiconductor material useful for an electrophotographic photoreceptor, has excellent film-forming propert...
|
|
JP2010265292A |
To provide new nitrosated nonsteroidal antiinflammatory drugs (NSAIDs) and pharmaceutically acceptable salts thereof, and methods for treating inflammation, pain and fever, for treating gastrointestinal disorders, and for facilitating wo...
|
|
JP2010535238A |
Described herein are cannabidiol prodrugs, methods of making cannabidiol prodrugs, formulations comprising cannabidiol prodrugs and methods of using cannabidiols. One embodiment described herein relates to the transdermal or topical admi...
|
|
JP4571497B2 |
An amino alcohol derivative represented by the following general formula (1) (for example, (±)-2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-
methylpentane-1-ol) exhibits strong immunosuppressive effect while causing less side ...
|
|
JP2010215643A |
To provide high purity bases of 3,3-diphenyl propylamine monoester, their production and their use as drugs, in particular for transdermal and transmucosal administration.A compound of general formula (I) is present as a free base with a...
|
|
JP4555401B2 |
The present invention features molecules with general structure (I) or (II) which can modulate on or activities of an inorganic ion receptor. Preferably, the molecule can mimic or block the effect of extracellular Ca<2+> on a calcium rec...
|
|
JP2010531156A |
The present invention provides a process for coating the surface of a substrate comprises the following steps (i) oxidizing the surface of the substrate (ii) applying a composition comprising one or more quaternary ammonium compounds car...
|
|
JP4544432B2 |
|
|
JP2010180218A |
To provide a new compound that stimulates a rate of glucose oxidation in myocardial cells.The compound is represented by formula (I). A pharmaceutical composition to stimulate glucose oxidation is obtained from the compound. Using the co...
|
|
JP4519969B2 |
|
|
JP4520310B2 |
The present invention is to provide a method of producing an N-alkylaminoalkyl (meth)acrylate containing a small amount of low boiling components, especially, containing a small amount of raw components, without any complicated operation...
|
|
JP4504559B2 |
The present invention relates to new lipopolyamines (including salts thereof) characterised by a symmetrical, highly flexible lipophilic moiety having buffering capacity at physiological pH, and to the use thereof for the in vivo or in v...
|
|
JP4500689B2 |
The present invention provides a compound represented by the following formula (I); [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; formula (I-1) represents a single bond or a double...
|
|
JP2010150425A |
To provide an organic device, especially an organic electroluminescent (EL) element, wherein a film is formed by a coating method, having high luminous efficiency and a long life, especially a long life when driven at high temperature, a...
|
|
JP4486350B2 |
|
|
JP4477178B2 |
|
|
JP4478790B2 |
A salt fusible at ordinary temperature which comprises: a cation ingredient obtained by introducing a cationic group into a volatile organic solvent; and an anion ingredient selected from the group consisting of an inorganic ion, sulfoni...
|
|
JP4460769B2 |
The present invention provides cationic surfactants derived from the amino derivatives of hexose alcohol, a reduced alcohol of hexose or reduced sugar of glucose, which is produced by converting 1-amino-hexose alcohol into a quaternary s...
|
|
JP2010090166A |
To provide a novel compound which stimulates glucose oxidation, has a long half-life and is effective on treating or preventing myocardial ischaemia.The compound which stimulates a glucose oxidation rate in myocardial cells is expressed ...
|
|
JP4455036B2 |
|
|
JP2010077155A |
To provide new crystals of ()2-(dimethylamino)-1-{[O-(m-methoxyphenetyl)phenoxy]methyl}
ethyl hydrogen succinate hydrochloride.There are provided type II crystals and type I crystals of ()2-(dimethylamino)-1-{[O-(m-methoxyphenetyl)phenox...
|
|
JP4446296B2 |
To provide a cationic surfactant composition excellent in fragrance. This cationic surfactant composition comprises a quaternary ammonium salt synthesized by using a fatty acid lower alkyl ester containing 10-50 wt.% monounsaturated lowe...
|
|
JP4444591B2 |
To provide a cationic surfactant which has high biodegradability, low irritativeness to the skins and the mucous membranes, and excellent hydrolysis stability. This cationic surfactant represented by the general formula (1), and the meth...
|
